2018 financial statements
A conference call will be held today, March 20, 2019, at 2:00pm (CEST) Management Participants: Mondher Mahjoubi, CEO, Laure-Helene Mercier, CFO, Pierre Dodion, CMO, and Jennifer Butler, US General Manager
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a fully integrated oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Headlines
ASH 2018: updated results on IPH4102 and KOL webcast
A KOL webcast and conference call was held on Tuesday, December 4, at 5pm CET (8am PST)
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
Conference call for analysts and investors to discuss this announcement.
Latest news
Upcoming events
Keystone Symposia, Innate and Non-Classical Immune Cells in Cancer Immunotherapy (C5) | Keystone, USA
March 24, 2019 to March 28, 2019
AACR Annual Meeting 2019 | Atlanta, USA
March 29, 2019 to April 3, 2019
6th Immunotherapy of Cancer Conference (ITOC6) | Vienna, Austria
April 11, 2019 to April 13, 2019